InDevR Inc. and Sino Biological, Inc. announced a new partnership to speed development of multiplexed assays for a broad range of vaccine, mRNA therapies and cell and gene therapy applications. Through this partnership, Sino Biological's catalog of high-quality antibodies, antigens, and other reagents are available for use on InDevR's VaxArray Platform. Biopharmaceutical companies worldwide currently employ the VaxArray Platform's multiplex assay capabilities in their vaccine testing to simplify, standardize and speed novel vaccine development, optimization of existing formulations and production scale-up.

The two companies aim to accelerate the development and deployment of multiparametric analytical tools to aid researchers in driving advancements in mRNA, vaccine development and the rapidly evolving field of cell and gene therapy. Since 2003, InDevR's core focus has been to deliver innovative analytical tools for the vaccine industry.